Biotech/Biomedical
News Category

Quantum BioPharma Taps Thermo Fisher to Launch Phase 2 Lucid-MS Trial, Advancing Novel Neuroprotective Approach to Multiple Sclerosis
Quantum BioPharma has signed a Study Start-Up Agreement with Thermo Fisher's clinical research business to execute a Phase 2 trial of Lucid-MS, a mult...

VERAXA Biotech Advances FDA-Aligned Methods to Reduce Animal Testing
VERAXA Biotech is implementing FDA-aligned New Approach Methodologies to cut animal testing in preclinical research, potentially accelerating cancer t...

SS Innovations Builds Telerobotic Surgery Position as Remote Procedures Gain Ground
SS Innovations International is advancing telerobotic surgery with its SSi Mantra system, reporting 195 telesurgeries and a 45% increase in installed ...

Lantern Pharma's Taiwan Approvals for HARMONIC Trial Expand Access to Promising Lung Cancer Therapy
Lantern Pharma's regulatory and IRB approvals in Taiwan for Part 2 of its Phase 2 HARMONIC trial of LP-300 mark a significant step forward in addressi...

Quantum BioPharma Engages Thermo Fisher to Launch Phase 2 Lucid-MS Trial, Advancing Novel Neuroprotective Approach to Multiple Sclerosis
Quantum BioPharma's agreement with Thermo Fisher's clinical research business to initiate a Phase 2 trial of Lucid-MS marks a strategic shift toward n...

VERAXA Biotech Advances FDA-Aligned Methods to Reduce Animal Testing in Preclinical Research
VERAXA Biotech (NASDAQ: VRXA) is implementing FDA-aligned New Approach Methodologies to reduce animal testing and accelerate the development of its an...

Quantum BioPharma Taps Thermo Fisher for Phase 2 Lucid-MS Trial, Advancing Novel Neuroprotective Approach to Multiple Sclerosis
Quantum BioPharma's Study Start-Up Agreement with Thermo Fisher's clinical research business moves its lead multiple sclerosis drug Lucid-MS into Phas...

XORTX Therapeutics Targets FDA New Drug Application for XORLO as Gout Prevalence Projected to Surge
XORTX Therapeutics is advancing XORLO, a proprietary oxypurinol formulation for gout, toward a New Drug Application with the FDA, addressing a growing...

C60 Power Marks National C60 Day, Spotlighting the Science and Purity of Carbon 60
C60 Power's National C60 Day on October 9 highlights the discovery of fullerenes and the growing interest in Carbon 60 research, while promoting educa...

C60 Power Marks National C60 Day, Spotlighting Fullerene Science and Wellness
C60 Power's National C60 Day on October 9 highlights the 1996 Nobel Prize in Chemistry for fullerenes and the growing consumer interest in Carbon 60 w...

Skull's Hidden Lymph Nodes May Revolutionize Brain Cancer Treatment
New research reveals that the skull harbors lymph node-like structures that could mobilize an immune response against brain diseases, potentially tran...

Gold Extends Recovery as Treasury Yields Drop, Rate Hike Expectations Fade
Gold prices rose for a second straight session on bargain buying, a weaker dollar, and falling Treasury yields, signaling a potential shift in Federal...

In Vitro ADME Studies Streamline Drug Development and Reduce Failure Risks
In vitro ADME studies are critical for early evaluation of drug candidates, helping to avoid costly late-stage failures and expedite the development o...

Heart-Brain Protection Pioneer Jennifer S. Lawton to Receive 2026 American Heart Association Basic Research Prize
Dr. Jennifer S. Lawton will receive the American Heart Association's 2026 Basic Research Prize for her pioneering translational research in myocardial...

GeoVax's Single-Dose MVA-X Vaccine Shows Durable Protection Against Lethal Clade I Mpox in Preclinical Study
GeoVax's preclinical data demonstrate that a single dose of its next-generation MVA-X vaccine provides durable protection against highly pathogenic Cl...

Financial Services Virtual Investor Conference to Highlight Capital Allocation Across Banking, Real Estate, and Digital Assets
The September 24 virtual investor conference will feature live presentations and Q&A with five financial services companies, emphasizing the importanc...

Marygold Companies Narrows Annual Loss as Strategic Shift Focuses on Core Fund Management
The Marygold Companies reported an 8% revenue increase for fiscal 2026 while reducing its net loss, as it divests non-core units and focuses on its pr...

Onco-Innovations Integrates Manufacturing and Preclinical Activities to Advance ONC010 Toward First-in-Human Testing
Onco-Innovations is aligning its manufacturing, preclinical, and clinical planning efforts to move its lead cancer candidate ONC010 toward potential f...

VERAXA Biotech Appoints Capital Markets Veteran Raju Willener as CFO to Drive Oncology Pipeline
VERAXA Biotech appoints Raju Willener as CFO, bringing over 30 years of capital markets experience to support the advancement of its BiTAC oncology pi...

Nano-X Imaging Builds Integrated Platform to Expand Access to Preventive Care
Nano-X Imaging is integrating digital X-ray hardware, AI, cloud software, and teleradiology into a single platform to enable earlier disease detection...

Apimeds Engages IBN to Boost Corporate Communications as Subsidiary Advances Digital Asset Infrastructure
Apimeds Pharmaceuticals US engages IBN to enhance corporate communications, aiming to raise investor awareness of its MindWave Innovations subsidiary'...

Regentis Biomaterials CEO Highlights GelrinC's Potential in U.S. and European Markets
Regentis Biomaterials is advancing its lead product GelrinC for knee cartilage repair, with a U.S. pivotal trial underway and European commercializati...

Silo Pharma Secures U.S. Patent Allowance for PTSD Therapeutic SPC-15, Strengthening Intellectual Property Portfolio
Silo Pharma has received a Notice of Allowance from the USPTO for a patent covering its lead PTSD therapeutic SPC-15, reinforcing its intellectual pro...

Goldman Sachs Predicts Another Fed Rate Hike in October Following September Increase
Goldman Sachs now expects the Federal Reserve to raise interest rates again in October after a unanimous September hike and indications of further tig...

Bacterial Strains Influence Meningitis, Pneumonia Risks from Air Pollution, New Study Finds
A new study reveals that the risk of sepsis, meningitis, or pneumonia from air pollution depends on individual bacterial strains, highlighting the nee...

Nightfood Holdings' TechForce Robotics Expands Into Pharmaceutical, Semiconductor, and Industrial Automation Markets
Nightfood Holdings is expanding its TechForce Robotics platform beyond hospitality into high-growth automation markets, including pharmaceutical and s...

Hong Kong-Led GoGlobal Task Force Delegation to Canada Aims to Strengthen Business Ties for Mainland Enterprises
Invest Hong Kong leads a delegation of Mainland Chinese companies to Canada to help them expand globally and attract Canadian investment in sustainabi...

Peptide Wholesale Supply Expands HPLC Verification to Bulk Semaglutide and Tirzepatide Orders
Peptide Wholesale Supply now provides HPLC chromatographic data with every bulk order of BPC-157, Semaglutide, and Tirzepatide, enhancing analytical t...

Early Clinical Trial Discussions Urged for Small Cell Lung Cancer Patients
New guidance from experts emphasizes that small cell lung cancer patients should ask about clinical trials at their first appointment, as emerging the...

Regentis Biomaterials Advances GelrinC as Potential New Approach to Knee Cartilage Repair
Regentis Biomaterials is developing GelrinC, an off-the-shelf hydrogel implant that supports cartilage regeneration, with early clinical data and a pi...

ORGANA International's ECRM Meetings Signal Major Retail Expansion Push
ORGANA International is meeting with retail buyers at the ECRM Vitamin, Weight Management & Sports Nutrition Session to expand its U.S. retail presenc...

Med-X Advances Nature-Cide Pest Control Platform Ahead of Planned Nasdaq Listing
Med-X is expanding its Nature-Cide natural pest control brand and securing certifications as it prepares for a Nasdaq debut, potentially disrupting th...

Telomir-Zn Shows Growth Inhibition in Human and Canine Osteosarcoma Models
Telomir Pharmaceuticals reports that Telomir-Zn inhibited growth in human and canine osteosarcoma cell lines at similar low concentrations, supporting...

Quantum BioPharma's FDA Clearance of Lucid-MS IND Opens Path to Phase 2 Trial in Multiple Sclerosis
Quantum BioPharma's FDA clearance of its Lucid-MS IND allows the company to proceed directly to a Phase 2 trial in multiple sclerosis, potentially acc...

GeoVax and CEPI Partner to Independently Evaluate GEO-MVA in Phase 3 Trial, Aiming to Diversify Global Mpox Vaccine Supply
GeoVax has secured access to CEPI's Centralised Laboratory Network for independent testing of its MVA-based mpox vaccine candidate, GEO-MVA, in a pivo...

Aortic Stiffness May Drive Midlife Pulse Pressure Rise in Women, Not Menopause
New research from the Framingham Heart Study suggests that aortic stiffening, not menopause, drives the rise in pulse pressure in women starting decad...

Dental Design Studios Expands to Nine Phoenix Offices, Broadening Access to Full Arch Implants and Urgent Care
Dental Design Studios' expansion to nine Phoenix-area locations increases access to full arch implants, cosmetic dentistry, and same-day emergency car...

Engineered Suppressor tRNAs Show Promise as Universal Therapy for Duchenne Muscular Dystrophy
Preclinical research published in Science Advances demonstrates that engineered suppressor tRNAs can restore full-length dystrophin and improve muscle...

Translational Longevity Emerges as Key to Delivering Longevity Science to Patients
The August Wellness Index Report highlights translational longevity as the critical discipline for turning laboratory breakthroughs into real-world pa...

Creative Biolabs Expands Functionalized Lipid-Based Delivery Systems to Overcome Key Delivery Barriers
Creative Biolabs has expanded its functionalized lipid-based delivery system development capabilities to help researchers engineer targeted and stimul...

Dr. Thanapoom Boonipat Scholarship for Future Doctors Offers $1,000 to Aspiring Physicians Nationwide
The Dr. Thanapoom Boonipat Scholarship for Future Doctors provides a $1,000 one-time award to undergraduate students nationwide who are committed to b...

LiverRight and Aegle Medical Solutions Partner to Expand Access to Liver Disease Detection and Care
The strategic partnership combines advanced non-invasive liver assessment technology with virtual specialist interpretation to improve liver disease d...

Creative Biolabs Expands Single-Cell Multi-Omics and RNA Sequencing Solutions to Accelerate Biomedical Discovery
Creative Biolabs has enhanced its single-cell multi-omics and RNA sequencing services to help researchers overcome sample processing challenges and un...

Tumor Microenvironment Drives Natural Killer Cell Diversity, Reshaping Cancer Immunotherapy Landscape
A new review reveals that the tumor microenvironment actively shapes natural killer cells into distinct subsets with specialized roles, offering a new...

Nanox Expands into Costa Rica with Nanox.ARC Distribution Agreement
Nano-X Imaging signs a distribution agreement for its Nanox.ARC system in Costa Rica, marking its third Latin American market this year and advancing ...

Life Sciences Investor Forum to Showcase Breakthrough Therapies and Real-Time Management Access
The September 17 Life Sciences Virtual Investor Forum will feature seven companies presenting advancements in cancer therapy, antibiotics, drug delive...


